EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Expanding the Utility of Exome Sequencing in Preventive and Population Genetics

Charilaos Kostoulas iD, Athanasia Sesse, Ioanna Bouba, Robert Najdecki, Spyridon Konitsiotis, Sofia Markoula, Ioannis Georgiou

American Journal of Medical Genetics Part A · 2026

DOI: 10.1002/ajmg.a.70210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Charilaos Kostoulas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics in Clinical Practice, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Exome Sequencing, Genetics, Population, Exome, Genetic Carrier Screening. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carrier screening is a long‐standing genetic testing process offered to at‐risk couples, with or without a family history, who might have pregnancies affected by an autosomal recessive (AR) or X‐linked (XL) disorder. A total of 276 unrelated individuals, initially referred for rare disorder screening by clinicians, were enrolled in this study and tested by Exome sequencing (ES). Expanded carrier screening (ECS) was performed for 176 disorders that met the inclusion criteria of the ACMG and ACOG. Genes with single nucleotide variants (SNVs) identified with a carrier rate > 1% for AR disorders included HBB , CFTR , PMM2 , NPHS2 , GJB2 , ACADM , ALDOB , MEFV , MKS1 , NEB , PAH , ATM , CPT2 , CYP21A2 , AGXT , BBS1 , CAPN3 , COL4A4 , DHCR7 , GAA , IVD , LAMA2 , SLC22A5 , SLC26A4 , USH2A . For XL disorders, variants were detected in the RS1 gene. ECS offers a wealth of information about SNVs related to AR and XL disorders in specified populations. The information obtained from ECS provides multiple advantages: (a) it identifies the most prominent risks in health care in a given population and contributes to the prevention of genetic disorders, (b) it enriches available databases with pathogenic or likely pathogenic SNVs, and (c) it records novel targets for molecular clinical genetic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingGenetics, PopulationExomeGenetic Carrier ScreeningGenetic Diseases, X-LinkedHumansFemaleGenetic TestingPolymorphism, Single NucleotideMaleGenes, Recessive

Stichwörter der Autor:innen

ACMGACOGallele frequencyat‐risk couplesexome sequencingexpanded carrier screening

Autor:innen und Institutionen

  • Laboratory of Medical Genetics in Clinical Practice, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
  • Assisting Nature, Centre of Reproduction and Genetics, Thessaloniki, Greece.
  • Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

ORCID-Profile: Charilaos Kostoulas

Zitieren

APA

Kostoulas, C., Sesse, A., Bouba, I., Najdecki, R., Konitsiotis, S., Markoula, S., & Georgiou, I. (2026). Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.70210

Vancouver

Kostoulas C, Sesse A, Bouba I, Najdecki R, Konitsiotis S, Markoula S, et al. Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.70210

BibTeX
@article{Kostoulas2026,
  author = {Kostoulas, Charilaos and Sesse, Athanasia and Bouba, Ioanna and Najdecki, Robert and Konitsiotis, Spyridon and Markoula, Sofia and Georgiou, Ioannis},
  title = {Expanding the Utility of Exome Sequencing in Preventive and Population Genetics},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  doi = {10.1002/ajmg.a.70210}
}
Kostenlos starten →